Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC), also called pancreatic cancer is predicted to become the 2nd frequent cause of cancer related death by 2030 (1,2). Recent studies have found that the tumor microenvironment characterized by ample stromal cells and a complex extracellular matrix composition are the main contributing factors. Genetic mutations such as point mutations, insertions, deletions, amplifications, translocations, fusions and inversions are frequently seen in PDACS.

pancreatic-cancer img

Genes mutated in PDAC

KRAS TP53 CDKN2A SMAD4 RNF43 ARID1A PRM1 GNAS RREB1 TGFBR2

OriGene has the largest collection Mutant ORF Clones that are conveniently cloned in mammalian expression and dual tagging vector and is available as transfection ready DNA. In addition, here are other tools for analyzing genes associated with PDAC.



Pancreatic cancer tissue controls

Frozen sections Tissue Protein Lysates Total RNA FFPE Sections Genomic DNA Tissue Scan

References:

  1. Sun H, Zhang B, Li H. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment. Technol Cancer Res Treat. 2020;19.
  2. Waters AM, Der CJ. KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer. Cold Spring Harb Perspect Med. 2018,8(9)